Slide 1: 2025 Investor Presentation
2025 Investor Presentation © 2025 Exponent, Inc. | Privileged & Confidential 1
Slide 2: Forward Looking Statements & Non-GAAP Financial Measures
Forward Looking Statements & Non-GAAP Financial Measures This presentation release contains, and incorporates by reference, certain “forward-looking” statements (as such term is defined in the Private Securities Litigation Reform Act of 1995, and the rules promulgated pursuant to the Securities Act
Slide 3: Premium Engineering & Scientific Consulting
Premium Engineering & Scientific Consulting When Getting it Right Matters Exponent harnesses the power of technical excellence, objectivity and disciplinary diversity to solve our clients’ toughest challenges © 2025 Exponent, Inc. | Privileged & Confidential 3
Slide 4: World's Best Problem Solvers for More than Five Decades
World’s Best Problem Solvers for More than Five Decades OVERVIEW OUR WORLD CLASS TALENT • 50+ years of expansion and diversification across disciplines and industries 900+ 650+ 90+ Consulting Doctoral-level Disciplines • Best-in-class engineering and scientific expertise Staff professionals • Bespok
Slide 5: Proven Track Record of Results
Proven Track Record of Results STRONG FINANCIAL POSITION COMPELLING INVESTMENT THESIS • Positioned to capitalize on increasing demand for a safer, healthier, more sustainable world • Wide competitive moat through unique multi- disciplinary solutions and world class talent $559M 28% • Strategic resou
Slide 6: 50+ Years of Future-Focused Thinking
50+ Years of Future-Focused Thinking Our ecosystem of intellectual capital evolves continuously, enabling Exponent — and our clients — to develop the solutions of tomorrow, today. Acquired Failure Analysis Expansion: Test Environmental Health Project: Cruise, Associates (FaAA) and Engineering Strate
Slide 7: Connecting the Lessons of Past Failures with Tomorrow's Solutions
Connecting the Lessons of Past Failures with Tomorrow’s Solutions We leverage our wealth of failure analysis learnings to develop the breakthrough insights our clients need, generating opportunity at every stage of the product lifecycle. Reactive Services Design Proactive Services Prototype Understa
Slide 8: Our History of Growth & Diversification
Our History of Growth & Diversification The evolution of Exponent’s ground-breaking capabilities is reflected in the progressive expansion of our client engagements — and ability to translate our reactive experience into new, untapped areas through innovation and agility. 2024 1967 Reactive Proactiv
Slide 9: Diversified Portfolio Provides Resilience
Diversified Portfolio Provides Resilience CONSUMER ENERGY TRANSPORTATION CHEMICALS LIFE SCIENCES CONSTRUCTION PRODUCTS & HEALTHCARE Reactive Proactive Reactive work driven by disputes and failure analysis work across the globe which have historically been less impacted by challenging economic cycles
Slide 10: Diverse Customer Relationships
Diverse Customer Relationships 10 Our Clients 10K 2K FY24 FY24 Engagements Clients Corporate Legal Government Deep Industry Know-How Construction Chemicals Consumer Electronics Energy Food Government Products & Beverage Software Industrial Life Sciences Mining & Computer Transportation Utilities & M
Slide 11: Strong Growth Momentum Through Safety, Health & Environmental Trends
Strong Growth Momentum Through Safety, Health & Environmental Trends CONSUMER LIFE SCIENCES TRANSPORTATION UTILITIES ELECTRONICS CHEMICAL & HEALTHCARE Key • Automation • Energy transition • Augmented and • Digital health • Human health Drivers / • virtual reality effects Trends • Electrification • C
Slide 12: Our Bespoke Multidisciplinary Teams
Our Bespoke Multidisciplinary Teams Exponent’s flexibility to build the right team at the right time is truly unrivaled. Polymers & Chemistry Environmental & Earth Sciences Ecological & Biological Sciences Biomedical Engineering & Sciences Chemical Regulation & Food Safety Mechanical Engineering The
Slide 13: Our Bespoke Multidisciplinary Teams
Our Bespoke Multidisciplinary Teams Exponent’s flexibility to build the right team at the right time is truly unrivaled. Polymers & Chemistry Environmental & Earth Sciences Ecological & Biological Sciences Biomedical Engineering & Sciences Mechanical Engineering v Regulation & Food Safety Chemical T
Slide 14: Our Bespoke Multidisciplinary Teams
Our Bespoke Multidisciplinary Teams Exponent’s flexibility to build the right team at the right time is truly unrivaled. Polymers & Chemistry Environmental & Earth Sciences Ecological & Biological Sciences Biomedical Engineering & Sciences Chemical Regulation & Food Safety Mechanical Engineering The
Slide 15: Our Bespoke Multidisciplinary Teams
Our Bespoke Multidisciplinary Teams Exponent’s flexibility to build the right team at the right time is truly unrivaled. Polymers & Chemistry Environmental & Earth Sciences Ecological & Biological Sciences Biomedical Engineering & Sciences v Chemical Regulation & Food Safety Mechanical Engineering T
Slide 16: World-Class Culture & Talent
World-Class Culture & Talent Attracting, developing, and rewarding exceptional people with diverse backgrounds and expertise is central to Exponent’s mission. Recruiting Sourcing candidates from increasingly diverse backgrounds and skill sets Outreach People Development Leveraging science, Seminar s
Slide 17: Financial Highlights
Financial Highlights © 2025 Exponent, Inc. | Privileged & Confidential 17
Slide 18: Proven Financial Results
Proven Financial Results Revenue ($M) EBITDA Margin1,2 (%) $600 $559 34 $513 $536 30.4 29.6 27.4 27.7 28.4 $466 27 $450 $417 $400 25.5 $300 17 $150 8.5 $0 2019 2020 2021 2022 2023 2024 0 2019 2020 2021 2022 2023 2024 Dividends Paid ($M) 58 Free Cash Flow ($M) 60 138 54 140 49 117.7 43.2 111 45 39.78
Slide 19: Capital Allocation
Capital Allocation Cash and Short Term Investments ($M): 2019-2024 300 297.7 2019-2024 258.9 Cash Returned to 242.5 231.6 Shareholders: 225 $278M 161.5 187.2 Dividend Payments 150 $255M 75 Repurchased Shares (or ~3.2M shares) 0 2019 2020 2021 2022 2023 2024 © 2025 Exponent, Inc. | Privileged & Confi
Slide 20: Key Metrics – Q1 2025
Key Metrics – Q1 2025 ($ Millions, except where noted) 2024 2025 % Change 20 Revenues Before Reimbursements $137.2 $137.4 n/m Revenues 144.9 145.5 n/m EBITDA1 $40.1 $37.5 -6% EBITDA Margin2 (%) 29.2% 27.3% Net Income 30.1 26.7 -11% Earnings per share ($) 0.59 0.52 -12% Average diluted shares outstan
Slide 21: Key Metrics – Fiscal Year 2024
Key Metrics – Fiscal Year 2024 ($ Millions, except where noted) 2023 2024 % Change 21 Revenues Before Reimbursements $497.2 $518.5 4% Revenues 536.8 558.5 4% EBITDA1 137.7 147.1 7% EBITDA Margin2 (%) 27.7% 28.4% Net Income 100.3 109.0 9% Earnings per share ($) 1.94 2.11 9% Average diluted shares out
Slide 22: Positioned at the Center of Global Macro Trends
Positioned at the Center of Global Macro Trends Health Safety Environment © 2025 Exponent, Inc. | Privileged & Confidential 22
Slide 23: Appendix
Appendix © 2025 Exponent, Inc. | Privileged & Confidential 23
Slide 24: EBITDAS – Q1 2025
EBITDAS – Q1 2025 ($ Millions) 2024 2025 % Change 24 Net Income $30.1 $26.7 -11% Add back (subtract): Income taxes 10.3 11.1 8% Interest income, net (2.6) (2.7) 3% Depreciation and amortization 2.3 2.5 7% EBITDA1 40.1 37.5 -6% Stock-based compensation 7.3 8.2 11% EBITDAS1 $47.5 $45.7 -4% 1EBITDA is
Slide 25: EBITDAS – Fiscal Year 2024
EBITDAS – Fiscal Year 2024 ($ Millions) 2023 2024 % Change 25 Net Income $100.3 $109.0 9% Add back: Income taxes 35.6 38.4 8% Interest income, net (7.2) (10.0) 40% Depreciation and amortization 8.9 9.7 9% EBITDA1 137.7 147.1 7% Stock-based compensation 20.4 23.2 14% EBITDAS1 $158.0 $170.3 8% 1EBITDA